Conjugate Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 12
SKU : PH1515
180 pages
Report Summary
Table of Contents
List of Tables
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Conjugate Vaccines Market?
The Conjugate Vaccines Market is expected to grow at a CAGR of 9.5% during the forecast period 2024-2031.
Who are the key players in the Conjugate Vaccines Market?
Major players are GlaxoSmithKline plc, Merck & Co. Inc., Fablife, SutroVax Inc., Sanofi Pasteur SA., Pfizer, Sinovac Biotech Ltd., IDT Biologics GmbH, GreenSignal Bio Pharma Limited, Taj Pharmaceuticals Limited and Bavarian Nordic.
Related Reports
biotechnologyCombination Vaccines Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
pharmaceuticalsAnthrax Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 12
Starting from
$4350
pharmaceuticalsDengue Vaccine Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 12
Starting from
$4350
pharmaceuticalsMeningitis Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 12
Starting from
$4350
pharmaceuticalsDNA Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 12
Starting from
$4350
pharmaceuticalsCancer Vaccines Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 12
Starting from
$4350